BBHC
GMAB icon

Brown Brothers Harriman & Co’s Genmab GMAB Stock Holding History

Brown Brothers Harriman & Co’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.7K Sell
1,553
-93
-6% -$2.47K ﹤0.01% 1135
2026
Q1 		$44.2K Buy
1,646
+1,486
+929% +$44.5K ﹤0.01% 1063
2025
Q4 		$4.93K Sell
160
-1,164
-88% -$36.3K ﹤0.01% 1515
2025
Q3 		$40.6K Buy
1,324
+780
+143% +$19K ﹤0.01% 1039
2025
Q2 		$11.2K Hold
544
– – ﹤0.01% 1177
2025
Q1 		$10.7K Sell
544
-175
-24% -$3.67K ﹤0.01% 1061
2024
Q4 		$15K Buy
719
+491
+215% +$10.8K ﹤0.01% 1075
2024
Q3 		$5.56K Buy
228
+53
+30% +$1.42K ﹤0.01% 1146
2024
Q2 		$4.4K Hold
175
– – ﹤0.01% 1034
2024
Q1 		$5.23K Hold
175
– – ﹤0.01% 1040
2023
Q4 		$5.57K Hold
175
– – ﹤0.01% 994
2023
Q3 		$6.17K Hold
175
– – ﹤0.01% 1006
2023
Q2 		$6.65K Hold
175
– – ﹤0.01% 1021
2023
Q1 		$6.61K Hold
175
– – ﹤0.01% 1031
2022
Q4 		$7.42K Hold
175
– – ﹤0.01% 1051
2022
Q3 		$6K Hold
175
– – ﹤0.01% 1262
2022
Q2 		$6K Hold
175
– – ﹤0.01% 1107
2022
Q1 		$6K Hold
175
– – ﹤0.01% 1102
2021
Q4 		$7K Hold
175
– – ﹤0.01% 966
2021
Q3 		$8K Hold
175
– – ﹤0.01% 936
2021
Q2 		$7K Hold
175
– – ﹤0.01% 941
2021
Q1 		$6K Sell
175
-637
-78% -$24K ﹤0.01% 937
2020
Q4 		$33K Buy
812
+231
+40% +$8.63K ﹤0.01% 725
2020
Q3 		$21K Sell
581
-116
-17% -$4.19K ﹤0.01% 689
2020
Q2 		$24K Buy
+697
New +$19K ﹤0.01% 662

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Brown Brothers Harriman & Co's GMAB Position: Q2 2026 in Review

Brown Brothers Harriman & Co reduced its Genmab (GMAB) stake by 5.7% in Q2 2026, selling an estimated $2.47K and leaving 1,553 shares worth $42.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1135.

Brown Brothers Harriman & Co first reported a position in GMAB in Q2 2020 and has held it in 25 quarters since. The position peaked at $44.2K in Q1 2026. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Brown Brothers Harriman & Co held 1,553 shares of Genmab worth $42.7K as of Q2 2026.
  • Brown Brothers Harriman & Co sold 93 Genmab shares in Q2 2026, an estimated $2.47K.
  • Genmab made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #1135 holding.
  • Brown Brothers Harriman & Co first reported a position in Genmab in Q2 2020 and has held it in 25 quarters since.
  • Brown Brothers Harriman & Co's Genmab position peaked at $44.2K in Q1 2026.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.